Therapeutic drug monitoring of β-lactams for critically ill patients: unwarranted or essential?

被引：50
|
作者：
Roberts, Jason A. [1 ,2 ,3 ]
Hope, William W. [4 ]
Lipman, Jeffrey [1 ]
机构：
[1] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Dept Intens Care, Brisbane, Qld 4029, Australia
[3] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld 4029, Australia
[4] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Translat Res Facil Resp Med, Univ Hosp S Manchester NHS Fdn Trust, Manchester, Lancs, England
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2010年 / 35卷 / 05期
关键词：
ANTIBIOTIC-THERAPY; RATIONALE; SEPSIS;
D O I：
10.1016/j.ijantimicag.2010.01.022
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [41] The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
    Novy, Emmanuel
    Martiniere, Hugo
    Roger, Claire
    ANTIBIOTICS-BASEL, 2023, 12 (04):
  • [42] Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers
    Williams, Paul
    Cotta, Menino Osbert
    Tabah, Alexis
    Sandaradura, Indy
    Kanji, Salmaan
    Scheetz, Marc H.
    Imani, Sahand
    Elhadi, Muhammed
    Pardos, Sonia Luque
    Schellack, Natalie
    Sanches, Cristina
    Timsit, Jean Francois
    Xie, Jiao
    Farkas, Andras
    Wilks, Kathryn
    Roberts, Jason A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (02)
  • [43] Development and application of amphotericin B immunoassay for pharmacokinetic studies and therapeutic drug monitoring in critically ill patients
    Burkin, Maksim A.
    Surovoy, Yuri A.
    Arzumanian, Vera G.
    Galvidis, Inna A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2022, 218
  • [44] Insufficient Fluconazole Exposure in Pediatric Cancer Patients and the Need for Therapeutic Drug Monitoring in Critically Ill Children
    van der Elst, Kim C. M.
    Pereboom, Marieke
    van den Heuvel, Edwin R.
    Kosterink, Jos G. W.
    Scholvinck, Elisabeth H.
    Alffenaar, Jan-Willem C.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (11) : 1527 - 1533
  • [45] Pharmacokinetic variability and significance of therapeutic drug monitoring for broad-spectrum antimicrobials in critically ill patients
    Ryota Tanaka
    Journal of Pharmaceutical Health Care and Sciences, 11 (1)
  • [46] Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients
    Ye, Qinghua
    Wang, Qianlin
    Chen, Ziying
    Chen, Wenqian
    Zhan, Qingyuan
    Wang, Chen
    CLINICAL RESPIRATORY JOURNAL, 2022, 16 (05): : 402 - 412
  • [47] Empirical Models for Dosage Optimization of Four β-Lactams in Critically III Septic Patients Based on Therapeutic Drug Monitoring of Amikacin
    Delattre, I. K.
    Musuamba, F. T.
    Verbeeck, R. K.
    Dugernier, T.
    Spapen, H.
    Laterre, P. F.
    Taccone, F. S.
    Vincent, J. L.
    Jacobs, F.
    Wallemacq, P. E.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 656 - 656
  • [48] Therapeutic drug monitoring of beta-lactams in critical ill patients: A prospective monocentric feedback of the SFPT and SFAR guidelines
    Jacquet, M.
    Bartoli, M.
    Caspar, Y.
    Gautier-Veyret, E.
    Stanke-Labesque, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 100 - 101
  • [49] Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
    Neugebauer, Sophie
    Wichmann, Christina
    Bremer-Streck, Sibylle
    Hagel, Stefan
    Kiehntopf, Michael
    THERAPEUTIC DRUG MONITORING, 2019, 41 (01) : 29 - 37
  • [50] Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients-A Narrative Review
    Stasek, Jan
    Keller, Filip
    Koci, Veronika
    Klucka, Jozef
    Klabusayova, Eva
    Wiewiorka, Ondrej
    Strasilova, Zuzana
    Benovska, Miroslava
    Skardova, Marketa
    Malaska, Jan
    ANTIBIOTICS-BASEL, 2023, 12 (03):
12345